2010
DOI: 10.1073/pnas.1005572107
|View full text |Cite
|
Sign up to set email alerts
|

ELOVL1 production of C24 acyl-CoAs is linked to C24 sphingolipid synthesis

Abstract: Very long-chain fatty acids (VLCFAs) exert a variety of cellular functions and are associated with numerous diseases. However, the precise pathway behind their elongation has remained elusive. Moreover, few regulatory mechanisms for VLCFAs synthesis have been identified. Elongases catalyze the first of four steps in the VLCFA elongation cycle; mammals have seven elongases (ELO-VL1-7). In the present study, we determined the precise substrate specificities of all the ELOVLs by in vitro analyses. Particularly no… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

27
362
0
1

Year Published

2015
2015
2024
2024

Publication Types

Select...
7

Relationship

2
5

Authors

Journals

citations
Cited by 306 publications
(390 citation statements)
references
References 34 publications
27
362
0
1
Order By: Relevance
“…The codons under diversifying selection can be observed in Figure 4 and in Tables S4 and S5. Branch 4, which includes sequences that clustered with functionally characterized Elovl4 proteins (Ohno et al., 2010), was observed to have 15 codons under episodic diversifying selection with a posterior probability ≥ 0.95. The remaining branches are observed to have between 11 and 14 codons under episodic diversifying selection with a posterior probability ≥ 0.95.…”
Section: Resultsmentioning
confidence: 99%
“…The codons under diversifying selection can be observed in Figure 4 and in Tables S4 and S5. Branch 4, which includes sequences that clustered with functionally characterized Elovl4 proteins (Ohno et al., 2010), was observed to have 15 codons under episodic diversifying selection with a posterior probability ≥ 0.95. The remaining branches are observed to have between 11 and 14 codons under episodic diversifying selection with a posterior probability ≥ 0.95.…”
Section: Resultsmentioning
confidence: 99%
“…Mammals have six ceramide synthases (CERS1-6) and seven FA elongases (ELOVL1-7), and each exhibits characteristic substrate specificity (Fig. S2B) (2,4,5,28). When CYP4F22 was expressed in these cells producing different ceramide species, ω-hydroxyceramides were produced in cells producing C26 ceramide (ELOVL1/CERS3 combination) and ≥C26 ceramides (the ELOVL4/CERS3 combination) but not in cells producing C22-C24 ceramides (the ELOVL1/CERS2 combination) (Fig.…”
Section: Resultsmentioning
confidence: 99%
“…To examine this possibility, we prepared HEK 293T cells producing different sets of ceramides with specific chain lengths by introducing particular combinations of ceramide synthase and FA elongase (ELOVL1 and CERS2, C22-C24 ceramides; ELOVL1 and CERS3, C26 ceramide; and ELOVL4 and CERS3, ≥C26 ceramides) (Fig. 5C) (28,29). Mammals have six ceramide synthases (CERS1-6) and seven FA elongases (ELOVL1-7), and each exhibits characteristic substrate specificity (Fig.…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…Each amplified DNA fragment was cloned into the pGEM-T Easy vector (Promega, Fitchburg, WI). Human CERS2, CERS3, and CERS4 cDNAs cloned into the pGEM-T Easy vector have been described previously (29,30 Table 1) were constructed using the overlap extension PCR (for mutant (MT) forms of human CERS2-6) or QuikChange site-directed mutagenesis kit (Agilent Technologies, Santa Clara, CA) (for MTs of mouse Cers2), with appropriate WT plasmid as a template and primers (for CERS2 (4A), CERS2-4A-F and CERS2-4A-R; for CERS3 (S340A), CERS3-S340A-F and CERS3-S340A-R; for CERS4 (4A), CERS4 -4A-F and CERS4 -4A-R; for CERS5 (4A), CERS5-4A-F and CERS5-4A-R; for CERS6 (4A), CERS6 -4A-F and CERS6 -4A-R; for Cers2 (S341A), Cers2-S341-F and Cers2-S341-R; for Cers2 (T346A), Cers2-T346-F and Cers2-T346-R; for Cers2 (S348A), Cers2-S348-F and Cers2-S348-R; for Cers2 (S349A), Cers2-S349-F and Cers2-S349-R; for Cers2 (4A), Cers2-4A-F and Cers2-4A-R) ( Table 2). Each cDNA fragment was excised from the corresponding pGEM-T Easy-based plasmid and cloned into a mammalian expression vector pCE-puro HA-1, which is designed to produce a protein fused to an N-terminal HA tag under control of the human elongation factor 1␣ promoter (31).…”
Section: Methodsmentioning
confidence: 99%